Literature DB >> 10837783

Immunoliposomes for the targeted delivery of antitumor drugs.

.   

Abstract

This review presents an overview of the field of immunoliposome-mediated targeting of anticancer agents. First, problems that are encountered when immunoliposomes are used for systemic anticancer drug delivery and potential solutions are discussed. Second, an update is given of the in vivo results obtained with immunoliposomes in tumor models. Finally, new developments on the utilization of immunoliposomes for the treatment of cancer are highlighted.

Entities:  

Year:  1999        PMID： 10837783     DOI： 10.1016/s0169-409x(99)00043-5

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN： 0169-409X            Impact factor:   15.470


  19 in total

1.  Can nanotechnology potentiate photodynamic therapy?

Authors:  Ying-Ying Huang; Sulbha K Sharma; Tianhong Dai; Hoon Chung; Anastasia Yaroslavsky; Maria Garcia-Diaz; Julie Chang; Long Y Chiang; Michael R Hamblin
Journal:  Nanotechnol Rev       Date:  2012-03       Impact factor: 7.848

2.  Cytosolic delivery of liposomally targeted proteins induced by photochemical internalization.

Authors:  Marjan M Fretz; Anders Høgset; Gerben A Koning; Wim Jiskoot; Gert Storm
Journal:  Pharm Res       Date:  2007-05-31       Impact factor: 4.200

3.  Pharmacokinetics of differently designed immunoliposome formulations in rats with or without hepatic colon cancer metastases.

Authors:  G A Koning; H W Morselt; A Gorter; T M Allen; S Zalipsky; J A Kamps; G L Scherphof
Journal:  Pharm Res       Date:  2001-09       Impact factor: 4.200

Review 4.  Engineering nanomedicines for improved melanoma therapy: progress and promises.

Authors:  Di Bei; Jianing Meng; Bi-Botti C Youan
Journal:  Nanomedicine (Lond)       Date:  2010-11       Impact factor: 5.307

5.  Half-antibody functionalized lipid-polymer hybrid nanoparticles for targeted drug delivery to carcinoembryonic antigen presenting pancreatic cancer cells.

Authors:  Che-Ming Jack Hu; Sharmeela Kaushal; Hop S Tran Cao; Santosh Aryal; Marta Sartor; Sadik Esener; Michael Bouvet; Liangfang Zhang
Journal:  Mol Pharm       Date:  2010-06-07       Impact factor: 4.939

Review 6.  Challenges in design and characterization of ligand-targeted drug delivery systems.

Authors:  Silvia Muro
Journal:  J Control Release       Date:  2012-06-15       Impact factor: 9.776

7.  In vitro cellular handling and in vivo targeting of E-selectin-directed immunoconjugates and immunoliposomes used for drug delivery to inflamed endothelium.

Authors:  Maaike Everts; Gerben A Koning; Robbert J Kok; Sigridur A Asgeirsdóttir; Dietmar Vestweber; Dirk K F Meijer; Gert Storm; Grietje Molema
Journal:  Pharm Res       Date:  2003-01       Impact factor: 4.200

8.  Tumor-specific targeting of sodium borocaptate (BSH) to malignant glioma by transferrin-PEG liposomes: a modality for boron neutron capture therapy.

Authors:  Atsushi Doi; Shinji Kawabata; Kyoko Iida; Kunio Yokoyama; Yoshinaga Kajimoto; Toshihiko Kuroiwa; Takashi Shirakawa; Mitsunori Kirihata; Satoshi Kasaoka; Kazuo Maruyama; Hiroaki Kumada; Yoshinori Sakurai; Shin-Ichiro Masunaga; Koji Ono; Shin-Ichi Miyatake
Journal:  J Neurooncol       Date:  2008-01-25       Impact factor: 4.130

9.  Preparation and property analysis of a hepatocyte targeting pH-sensitive liposome.

Authors:  Si-Yuan Wen; Xiao-Hong Wang; Li Lin; Wei Guan; Sheng-Qi Wang
Journal:  World J Gastroenterol       Date:  2004-01-15       Impact factor: 5.742

10.  Tumor-cell targeted epiderimal growth factor liposomes loaded with boronated acridine: uptake and processing.

Authors:  Erika Bohl Kullberg; Marika Nestor; Lars Gedda
Journal:  Pharm Res       Date:  2003-02       Impact factor: 4.200
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.